[1] Vaughn ED. Renovascular hypertension. Curr Opin Urol, 1998, 8(2):125-128.
[2] Taylor AT, Donald M, Dubovsky EV, et al. Procedure guideline for diagnosis of renovascular hypertension. Society of Nuclear Medicine Procedure guidelines manal, 2003.98-104.
[3] Fenves AZ, Ram CV. Renovascular hypertension:Clinical concepts.Minerva Med, 2006, 97(4):313-324.
[4] Kerut EK, Geraci SA, Faltman C, et al. Atherosclerotic renal artery stenosis and renalvascular hypertension:clinical diagnosis and indications for revascularization. J Clin Hypertens, 2006, 8(7):502-509.
[5] Jensen G, Moonen M, Aurell M, et al. Reliability of ACEI enhanced 99mTc-DTPA gamma camera renography in the detection of renovascular hypertension. Nucl Med Commun, 1993, 14(3):169-175.
[6] Grenier N, Hauger O, Cimpean A, et al. Update of renal imaging.Semin Nucl Med, 2006, 36(1):2-15.
[7] Mittal BR, Kumar P, Arora P, et al. Role of eaptopril renography in the diagnosis of renovascular hypertension. Am J Kidney Dis, 1996,28(2):209-213.
[8] Philippe F, Delphine M, Roselyne J, et al. Value of eaptopril scintigraphy in hypertension patients with renal failure. J Nucl Med,1999, 40(3):412-417.
[9] Ludwig V, Martin WH, Delbeke D. Calcium channel blockers:a potential cause of false-positive captopril renography. Clin Nucl Med, 2003, 28(2):108-112.
[10] Taylor AT, Nally J, Aurell M, et al. Procedure guideline for diagnosis of renovascular hypertension. J Nucl Med, 1998, 39(7):1297-1302.